Pulmonary Vein Ablation using Irreversible Electroporation - a safety study - Safety of PVI using IRE

niversitair Medisch Centrum Utrecht0 个研究点目标入组 20 人开始时间: 待定最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•* Patients age is * 18 years and * 80 years
•* Patients must provide written, informed consent
•* Patients with paroxysmal or persistent atrial fibrillation. Persistent AF is defined as sustained episodes of atrial fibrillation lasting >7 days.
•* Patients undergoing a first-time ablation procedure for atrial fibrillation
•* All pulmonary vein diameters at computed tomography or magnetic resonance imaging *26 mm
•* AF must be recorded at least once by ECG, holter, telemetry, loop recorder or internal device

•* Not capable of giving informed consent
•* Patients with longstanding persistent AF, defined as sustained episode lasting >1 year
•* Patients with any exclusion criteria or contra-indications for electrophysiologic study and ablation in the LA (under conscious sedation), such as pregnancy or presence of a LA thrombus
•* Patients that cannot undergo a contrast enhanced MRI-scan (e.g. implanted devices, renal function or anxiety)
•* Patients that cannot undergo an esophagoscopy

发起方

niversitair Medisch Centrum Utrecht